NECAP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.423000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.257100E-03
Normal-vs-Stage2
2.956200E-03
Normal-vs-Stage3
2.996000E-02
Normal-vs-Stage4
2.611600E-01
Stage1-vs-Stage2
1.446470E-02
Stage1-vs-Stage3
6.177400E-01
Stage1-vs-Stage4
2.945700E-02
Stage2-vs-Stage3
1.617370E-01
Stage2-vs-Stage4
2.073200E-01
Stage3-vs-Stage4
1.574950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.302400E-03
Normal-vs-AfricanAmerican
5.816700E-03
Normal-vs-Asian
4.152500E-02
Caucasian-vs-AfricanAmerican
4.365400E-01
Caucasian-vs-Asian
4.146800E-01
AfricanAmerican-vs-Asian
2.515200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.799060E-03
Normal-vs-Female
5.498400E-03
Male-vs-Female
2.450000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.902100E-02
Normal-vs-Age(41-60Yrs)
8.316900E-03
Normal-vs-Age(61-80Yrs)
1.782430E-03
Normal-vs-Age(81-100Yrs)
6.555800E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.676800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.757800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.533600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.962390E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.790400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.802400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.962400E-03
Normal-vs-Daily Drinker
1.401840E-02
Normal-vs-Weekly Drinker
8.022600E-03
Normal-vs-Occasional Drinker
1.098190E-02
Normal-vs-Social Drinker
3.579600E-03
Non Drinker-vs-Daily Drinker
2.202600E-01
Non Drinker-vs-Weekly Drinker
7.552600E-01
Non Drinker-vs-Occasional Drinker
1.404400E-01
Non Drinker-vs-Social Drinker
7.659800E-01
Daily Drinker-vs-Weekly Drinker
4.524600E-01
Daily Drinker-vs-Occasional Drinker
7.814000E-01
Daily Drinker-vs-Social Drinker
4.060600E-01
Weekly Drinker-vs-Occasional Drinker
3.053800E-01
Weekly Drinker-vs-Social Drinker
9.764600E-01
Occasional Drinker-vs-Social Drinker
2.575200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.767000E-01
Normal-vs-Grade 2
9.214800E-01
Normal-vs-Grade 3
9.327200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.741500E-03
Grade 1-vs-Grade 3
6.063700E-03
Grade 1-vs-Grade 4
8.767000E-01
Grade 2-vs-Grade 3
7.830800E-01
Grade 2-vs-Grade 4
9.214800E-01
Grade 3-vs-Grade 4
9.327200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.744700E-03
Normal-vs-NonDiabetic
1.544100E-03
Diabetic-vs-NonDiabetic
4.094200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.044190E-02
Normal-vs-NoPancreatitis
2.855900E-03
Pancreatitis-vs-NoPancreatitis
4.963600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.237420E-03
Normal-vs-N1
3.836200E-03
N0-vs-N1
9.838000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.535900E-03
Normal-vs-TP53-NonMutant
3.220300E-04
TP53-Mutant-vs-TP53-NonMutant
1.2869000000082E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
